Updated
Updated · CNBC · Jul 25
Nasdaq Drops 2.1% for Second Weekly Loss as Oil Surge and AI Capex Fears Hit Stocks
Updated
Updated · CNBC · Jul 25

Nasdaq Drops 2.1% for Second Weekly Loss as Oil Surge and AI Capex Fears Hit Stocks

3 articles · Updated · CNBC · Jul 25

Summary

  • The Nasdaq fell 2.1% and the S&P 500 lost 0.6%, marking a second straight weekly decline as investors absorbed Middle East escalation, rising crude and uneven earnings.
  • Brent briefly topped $100 a barrel after threats tied to Iran and Houthi attacks on Saudi tankers, lifting inflation worries and pushing markets to price a nearly 35% chance of a Fed rate hike next week, up from 13%.
  • Alphabet sharpened concern over AI spending discipline: despite strong results and 82% Google Cloud growth, the stock slid 7% after it raised 2026 capex guidance to $195 billion-$205 billion and signaled more spending in 2027.
  • Intel, GE Vernova and Dover showed the market's selective response to AI-linked names, with investors rewarding demand signals like Intel's 59% data-center revenue growth and GE Vernova's 88% order jump less than hoped while still punishing execution misses.
  • Outside tech, Eli Lilly gained on late-stage obesity-drug data and Johnson & Johnson rose after early FDA approval for its Ottava robot, underscoring that healthcare remained one of the week's few bright spots.

Insights

Despite a massive backlog, why is Wall Street punishing tech giants for building the very infrastructure that artificial intelligence demands?
With Middle East tensions pushing oil near $100, could an unexpected Fed rate hike suddenly derail the entire market next week?
Can a clever patent strategy protect a revolutionary new weight-loss drug from aggressive government price negotiations until the next decade?